butyric acid and glucagon-like peptide 1

butyric acid has been researched along with glucagon-like peptide 1 in 7 studies

Research

Studies (7)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	3 (42.86)	24.3611
2020's	4 (57.14)	2.80

Authors

Authors	Studies
Durham, HA; Finley, J; Gao, Z; Goldsmith, F; Greenway, F; Keenan, MJ; Martin, RJ; McCutcheon, KL; Pelkman, C; Raggio, AM; Senevirathne, RN; Vidrine, K; Williams, C; Ye, J; Zhou, J	1
Chen, W; Du, J; Fang, R; Hu, X; Liu, J; Liu, S; Sun, J; Wang, F; Xiong, J	1
Chen, YW; Fan, JG; Liu, XL; Pan, Q; Xin, FZ; Yang, RX; Zhao, ZH; Zhou, D; Zhou, H	1
Gong, L; Hu, X; Jiao, W; Liu, L; Sun, Z; Tang, H; Xu, Y; Zeng, S; Zhang, Q; Zhang, W; Zhang, Z	1
Chen, S; Du, L; Heng, C; Hu, Y; Jiang, Z; Lu, Q; Qian, S; Wang, H; Wang, J; Wang, T; Wang, Z; Yang, H; Yang, T; Yin, X; Yu, Q	1
Chen, TT; Chen, WJ; Huang, H; Jin, R; Tang, YH; Wang, XL; Wei, J; Xu, X; Zou, CW	1
Amiri, P; Hosseini, SA; Roshanravan, N; Saghafi-Asl, M; Tootoonchian, M	1

Trials

1 trial(s) available for butyric acid and glucagon-like peptide 1

Article	Year
The effects of sodium butyrate supplementation on the expression levels of PGC-1α, PPARα, and UCP-1 genes, serum level of GLP-1, metabolic parameters, and anthropometric indices in obese individuals on weight loss diet: a study protocol for a triple-blind Trials, 2023, Aug-01, Volume: 24, Issue:1 Topics: Adolescent; Adult; Butyric Acid; Diet, Reducing; Dietary Supplements; Glucagon-Like Peptide 1; Humans; Middle Aged; Obesity; PPAR alpha; Randomized Controlled Trials as Topic; Transcription Factors; Uncoupling Protein 1; Young Adult	2023

Article

Year

The effects of sodium butyrate supplementation on the expression levels of PGC-1α, PPARα, and UCP-1 genes, serum level of GLP-1, metabolic parameters, and anthropometric indices in obese individuals on weight loss diet: a study protocol for a triple-blind

Trials, 2023, Aug-01, Volume: 24, Issue:1

Topics: Adolescent; Adult; Butyric Acid; Diet, Reducing; Dietary Supplements; Glucagon-Like Peptide 1; Humans; Middle Aged; Obesity; PPAR alpha; Randomized Controlled Trials as Topic; Transcription Factors; Uncoupling Protein 1; Young Adult

2023

Other Studies

6 other study(ies) available for butyric acid and glucagon-like peptide 1

Article	Year
Resistant starch from high amylose maize (HAM-RS2) and dietary butyrate reduce abdominal fat by a different apparent mechanism. Obesity (Silver Spring, Md.), 2014, Volume: 22, Issue:2 Topics: Abdominal Fat; Adiposity; Amylose; Animals; Anti-Obesity Agents; Bifidobacterium; Butyric Acid; Cecum; Fermentation; Glucagon-Like Peptide 1; Intestinal Mucosa; Lactobacillales; Male; Obesity; Peptide YY; Plant Proteins; Plants, Genetically Modified; Prebiotics; Rats; Rats, Sprague-Dawley; Seeds; Starch; Zea mays	2014
Sodium butyrate exerts protective effect against Parkinson's disease in mice via stimulation of glucagon like peptide-1. Journal of the neurological sciences, 2017, Oct-15, Volume: 381 Topics: Animals; Antiparkinson Agents; bcl-2-Associated X Protein; Blood-Brain Barrier; Butyric Acid; Corpus Striatum; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Male; Mice, Inbred C57BL; MPTP Poisoning; Neuroprotective Agents; Occludin; Proto-Oncogene Proteins c-bcl-2; Random Allocation; Substantia Nigra; Tyrosine 3-Monooxygenase; Zonula Occludens-1 Protein	2017
Sodium butyrate reduces high-fat diet-induced non-alcoholic steatohepatitis through upregulation of hepatic GLP-1R expression. Experimental & molecular medicine, 2018, 12-03, Volume: 50, Issue:12 Topics: Adult; Animals; Butyric Acid; Diet, High-Fat; Disease Models, Animal; Disease Progression; Down-Regulation; Female; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Hep G2 Cells; Humans; Intestines; Liver; Male; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease	2018
Butyric acid normalizes hyperglycemia caused by the tacrolimus-induced gut microbiota. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2020, Volume: 20, Issue:9 Topics: Animals; Butyric Acid; Gastrointestinal Microbiome; Glucagon-Like Peptide 1; Hyperglycemia; Mice; Tacrolimus	2020
Amelioration of non-alcoholic fatty liver disease by sodium butyrate is linked to the modulation of intestinal tight junctions in db/db mice. Food & function, 2020, Dec-01, Volume: 11, Issue:12 Topics: Animals; Blood Glucose; Butyric Acid; Caco-2 Cells; Cholesterol; Clostridium butyricum; Colon; Cytokines; Diabetes Mellitus, Type 2; Exenatide; Glucagon-Like Peptide 1; Hep G2 Cells; Humans; Hypoglycemic Agents; Inflammation; Intestines; Lipid Metabolism; Liver; Male; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Receptors, G-Protein-Coupled; Tight Junctions; Triglycerides	2020
Engineered probiotics Clostridium butyricum-pMTL007-GLP-1 improves blood pressure via producing GLP-1 and modulating gut microbiota in spontaneous hypertension rat models. Microbial biotechnology, 2023, Volume: 16, Issue:4 Topics: Animals; Blood Pressure; Butyric Acid; Clostridium butyricum; Gastrointestinal Microbiome; Glucagon-Like Peptide 1; Hypertension; Hypertrophy; Probiotics; Rats; Rats, Inbred SHR	2023